National Comprehensive Cancer Network (NCCN). 2025 Jan 31.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Breast Cancer. Version 1.2025.
www.nccn.org/guidelines/guidelines-detail?category=1&id=1419
Nat Rev Immunol. 2025 Jan 31. IF: 67.7
Trained immunity in chronic inflammatory diseases and cancer.
www.nature.com/articles/s41577-025-01132-x
ACS Nano. 2025 Jan 31. IF: 15.8
Rationally Engineered Bispecific Nanoimmunoblocker Restores Anticancer Immunity via Dual Immune Checkpoint Blockade.
pubs.acs.org/doi/10.1021/acsnano.4c13463
Adv Sci (Weinh). 2025 Jan 30:e2412096. IF: 14.3
Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer.
www.onlinelibrary.wiley.com/doi/10.1002/advs.202412096
NPJ Digit Med. 2025 Jan 31;8(1):75. IF: 12.4
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology.
www.nature.com/articles/s41746-025-01471-y
JAMA Netw Open. 2025 Jan 31;8(1):e2457483. IF: 10.5
Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease.
www.jamanetwork.com/journals/jamanetworkopen/fullarticle/2829778
JAMA Netw Open. 2025 Jan 31;8(1):e2457495. IF: 10.5
Beyond Boundaries in ERBB2-Positive Brain Metastatic Breast Cancer.
www.jamanetwork.com/journals/jamanetworkopen/fullarticle/2829786
